tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
LGND is currently covered by 6 analysts with an average price target of $290.6. This is a potential upside of $30.51 (2.14%) from yesterday's end of day stock price of $284.52.
Ligand Pharmaceuticals's activity chart (see below) currently has 127 price targets and 115 ratings on display. The stock rating distribution of LGND is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 94.96% with an average time for these price targets to be met of 391.88 days.
Highest price target for LGND is $358, Lowest price target is $220, average price target is $290.6.
Most recent stock forecast was given by DOUGLAS MIEHM from RBC on 07-Aug-2026. First documented stock forecast 12-Feb-2014.
Currently out of the existing stock ratings of LGND, 21 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Jul-2024
$345
$58.71 (20.51%)
$340
Buy Since 12-Feb-2014
$358
$71.71 (25.05%)
$289
Buy Since 03-Oct-2024
$326
$39.71 (13.87%)
$147
Buy Since 10-Apr-2025
$332
$45.71 (15.97%)
Buy Since 11-Dec-2024
$277
$-26.59 (-8.76%)
$250
What is LGND (Ligand Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on LGND (Ligand Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on LGND (Ligand Pharmaceuticals)?
Which analyst is the currently most bullish on LGND (Ligand Pharmaceuticals)?
Which analyst is the currently most reserved on LGND (Ligand Pharmaceuticals)?
